Enanta Sets Chief Executive Succession Search
Source-gap recovery: on 28 October Enanta announced that Jay R. Luly plans to retire as president and CEO by 1 February 2027 after 23 years. The board has begun an internal and external successor…
Source-gap recovery: on 28 October Enanta announced that Jay R. Luly plans to retire as president and CEO by 1 February 2027 after 23 years. The board has begun an internal and external successor…
Verastem Oncology appointed director Michael P. Bailey as president and chief executive officer effective 1 January 2027. Daniel Paterson will retire from the CEO role, remain on the board through his current term, and…
Source-gap catch-up for a 5 October announcement. NeoGenomics appointed current president and COO Warren Stone to succeed Tony Zook as CEO on 4 January 2027. Zook will become executive chair; current chair Lynn Tetrault…